Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany

Objective: To evaluate real-world persistence and adherence in patients with benign prostate hyperplasia (BPH) receiving a fixed-dose combination of dutasteride plus tamsulosin (DUT-TAM FDC) versus α-blocker plus 5-α reductase inhibitor (AB/5ARI) free-combination therapy. Materials and methods: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisen, Christoph, Lulic, Zrinka, Palacios-Moreno, Juan Manuel, Adalig, Burkay, Hennig, Michael, Cortes, Vanessa, Gilg, Florian, Kostev, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921277/
https://www.ncbi.nlm.nih.gov/pubmed/31670653
http://dx.doi.org/10.5414/CP203549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921277/
https://www.ncbi.nlm.nih.gov/pubmed/31670653
http://dx.doi.org/10.5414/CP203549

Ejemplares similares